(Circulation. 2004;109:146-149.)
© 2004 American Heart Association, Inc.
Review: Clinical Cardiology: New Frontiers |
From the Cardiovascular Imaging Center, Cardiovascular Division, University of Virginia, Charlottesville, Va (S.K.), and the Cardiology Division, Sakurabashi Watanabe Hospital, Osaka, Japan (H.I.).
Correspondence to Sanjiv Kaul, MD, Cardiovascular Division, Box 800158, Medical Center, University of Virginia, Charlottesville, VA 22908-0158. E-mail sk{at}virginia.edu
| Introduction |
|---|
|
|
|---|
There is
45 mL of blood in the adult human coronary circulation (termed coronary blood volume), of which about one-third resides in the arterial, venous, and capillary networks each.1 At baseline,
8% of the left ventricular (LV) mass is constituted by blood present in the microcirculation, 90% of which is in the capillariestermed myocardial blood volume (MBV) (Figure 1).2 The velocity of blood in the coronary vessels is related to the size of the vessels, and at the level of the capillary (mean length 0.5 mm and mean diameter 7 µm), the mean red cell velocity at rest is
1 mm · s-1.2 There are
8 million capillaries in the human heart, and it takes 1 mL of blood
1 year to travel through a single capillary.2
|
The microcirculation not only consists of a channel of passive networks through which blood is transported through the myocardium, but is an active site of blood flow control as well as metabolic activity. Indeed, the regulation of flow through these networks is complicated and depends on a number of metabolic, myogenic, and other control mechanisms. The capillary hydrostatic pressure is held constant within the myocardium at all times at
30 mm Hg, with the pre- and postcapillary pressures at
45 and 15 mm Hg, respectively.3 The coronary arterioles (ranging in size from 150 to 300 µm) act as resistance vessels so that the aortic pressure (mean 90 mm Hg) is brought down to a precapillary pressure of 45 mm Hg. The arterioles have smooth muscles with a strong and immediate myogenic response such that the arteriolar resistance can change second to second to keep the precapillary pressure constant (autoregulation).
Coronary venules also have weak myogenic responses, and they also control local resistance by changing the rheological properties of blood. In addition, the venules are the site of leukocyte adhesion during inflammation. Their endothelial surfaces express a number of adhesion molecules, whose production is upregulated at different times after the onset of tissue injury.
| Myocardial Contrast Echocardiography |
|---|
|
|
|---|
2 to 3 minutes later, steady state is achieved when their concentration in any blood pool (LV cavity, myocardium, etc) is constant and proportional to the blood volume fraction of that pool. For example, during normal conditions, for every 100 microbubbles within a sample volume in the LV cavity, there will be 8 microbubbles within a similar-sized sample volume in the myocardium. The acoustic intensity measured from the myocardium after background subtraction (to eliminate native backscatter from myocardial tissue), when normalized to that from the LV cavity, provides a measure of myocardial MBV fraction (because LV cavity is 100% blood).7 Because 90% of MBV fraction comprises capillary blood, a single MCE image provides an assessment of capillary density in the different myocardial regions. At steady state, the microbubbles within the myocardium are destroyed with high-energy ultrasound pulse(s), so that there are no microbubbles seen any longer in the myocardium. Then imaging is performed to measure the rate of microbubble reappearance, which reflects RBC velocity (Figure 2).8 Because flow constitutes a volume of blood moving at a certain mean velocity, the product of MBV fraction and myocardial blood velocity reflects myocardial microvascular flow. This value can also be represented per gram of tissue by knowing the sample volume size and specific gravity of the myocardium, although for most clinical applications it is not necessary to do so.
|
| Stress-Induced Ischemia |
|---|
|
|
|---|
With MCE, it has been realized that MBV fraction decreases during hyperemia in the presence of a stenosis and that this decrease is proportional to the severity of stenosis.8,10 Because the majority of the MBV fraction is resident in capillaries, it follows that the capillary volume decreases. The length of a single capillary remains constant, and because capillaries do not have smooth muscle, they cannot dilate or constrict. Consequently, the only way capillary volume can decrease is if capillary units functionally shut off, resulting in a lower number of microbubbles in the myocardium and a resultant perfusion defect on MCE. The same mechanism is responsible for the occurrence of reversible perfusion defects with other noninvasive imaging methods.11 The lower number of functioning capillaries precludes entry of MRI contrast agents as well as radionuclides, resulting in perfusion defects during stress.
Figure 3 shows the distribution of resistances across the normal coronary circulation at baseline. As stated earlier, the mean aortic pressure of 90 mm Hg is reduced to a precapillary pressure of 45 mm Hg because of resistance offered by coronary arterioles. There is a further 30-mm drop in pressure across the capillary bed. The capillaries are very small and offer high resistance, but because they are arranged in parallel, the total capillary resistance decreases with an increasing number of capillaries. The drop across the venous bed is only 15 mm, because these are high capacitance vessels, which nevertheless have some smooth muscle. Thus, at rest,
60% of total myocardial vascular resistance is offered by the arterioles, 25% by the capillaries and 15% by the venules.10
|
| Importance of Capillary Resistance During Hyperemia |
|---|
|
|
|---|
|
The total resistance within the circulation equals the product of vascular resistance and viscosity. In large vessels (>30 µm in diameter), vascular resistance is the major determinant of total resistance, with viscosity playing a minor role. In vessels <30 µm in diameter, however, viscosity assumes a greater role, with relative effective viscosity increasing 6- to 7-fold at the level of the capillaries.12 Because the effect of vascular resistance and viscosity are multiplicative, small changes in viscosity produce a large difference in total resistance. Furthermore, it has also been demonstrated that unlike glass tubes, resistance in the same-sized capillaries is almost 2-fold higher for blood than isotonic fluid probably because of the interaction between the vessel lining and blood components.12
A number of studies have shown an increase in blood viscosity with hyperlipoproteinemia.1316 A strong positive correlation has been noted between increased blood viscosity and CAD.17 Several studies have shown abnormal CBF reserve even in patients with CAD risk factors in the absence of CAD on angiography. Furthermore, it has been shown that the use of lipid-lowering drugs (especially statins) can normalize abnormal CBF reserve without affecting coronary artery morphology.18 Reduced CBF reserve associated with hyperlipoproteinemia may lead to repeated episodes of exercise-induced ischemia, which may ultimately have a detrimental effect on microvascular and myocyte integrity.19 Similar effects could occur from hyperglycemia and may explain the higher cardiac morbidity in patients with uncontrolled diabetes. Thus, it in terms myocardial ischemia from microvascular abnormalities, the effect of whole blood viscosity and its association with RBC charge, deformability, and electrophoretic mobility is very important.
When a noncritical stenosis is present, its resistance is offset by a decrease in arteriolar resistance due to autoregulation, with the result that total vascular resistance remains unchanged, as does resting CBF. Now, when hyperemia is induced, although the total myocardial vascular resistance decreases compared with the resting state without stenosis, it increases compared with the nonhyperemic state with stenosis. During hyperemia, arteriolar and venular resistances are already minimal, so the increase in resistance occurs mostly from an increase in capillary resistance due to capillary derecruitment in an effort to keep the capillary hydrostatic pressure from rising. Thus, the major reason for attenuation of CBF reserve caused by a stenosis is also capillaries rather than the stenosis itself (Figure 4).10 The same mechanism operates even during dobutamine infusion, although the relative MBV of the entire myocardium increases because of the increase in myocardial oxygen demand and functional capillary recruitment.20
Capillary derecruitment combined with a lesser increase in RBC velocity forms the basis for stenosis detection in CAD. During hyperemia, the normal myocardium fills very fast after microbubble destruction (1 to 1.5 seconds), while in regions sub served by stenoses, the rate of filling is slower depending on the severity of stenosis. The filling abnormalities are frequently seen to be more marked in the endocardium and, in the case of milder stenoses, may be localized only within the endocardium.21 It is for this reason that MCE has been shown to be more sensitive than single-photon emission computed tomography (SPECT) for the detection of coronary stenoses in patients with normal regional function and only moderate CAD.22 Because of its poorer spatial resolution (order of magnitude) compared with MCE, SPECT cannot detect defects located only in the endocardium. MCE is also superior in identifying multivessel CAD because each myocardial segment at stress is compared with itself at rest (Figure 5), whereas on SPECT the comparison is across segments, so that left main or "balanced" multivessel CAD can be missed. Figure 5 is an example in which a reversible defect was seen both by MCE and SPECT in a patient with a moderate mid-left anterior descending artery stenosis.
|
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Kaul S, Jayaweera AR. Coronary and myocardial blood volumes: noninvasive tools to assess the coronary microcirculation? Circulation. 1997; 96: 719724.[Medline] [Order article via Infotrieve]
3. Jarhult J, Mellander S. Autoregulation of capillary hydrostatic pressure in skeletal muscle during regional arterial hypo- and hypertension. Acta Physiol Scand. 1974; 91: 3241.[Medline] [Order article via Infotrieve]
4. Lindner JR, Song J, Jayaweera AR, et al. Microvascular rheology of Definity micro-bubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr. 2002; 15: 396403.[CrossRef][Medline] [Order article via Infotrieve]
5. Keller MW, Segal SS, Kaul S, et al. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res. 1989; 65: 458467.
6. Jayaweera AR, Edwards N, Glasheen WP, et al. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography: comparison with radiolabeled red blood cells. Circ Res. 1994; 74: 11571165.
7. Le DE, Bin JP, Coggins M, et al. Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography. J Am Soc Echocardiogr. 2002; 15: 857863.[CrossRef][Medline] [Order article via Infotrieve]
8. Wei K, Firoozan S, Jayaweera AR, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a continuous infusion. Circulation. 1998; 97: 473482.
9. Gould KL, Lipscomb K. Effects on coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974; 34: 4855.[CrossRef][Medline] [Order article via Infotrieve]
10. Jayaweera AR, Wei K, Coggins M, et al. Role of capillaries in determining coronary blood flow reserve: new insights using myocardial contrast echocardiography. Am J Physiol. 1999; 277: H2363H2372.[Medline] [Order article via Infotrieve]
11. Wei K, Le E, Bin JP, et al. Mechanism of reversible 99mTc-sestamibi perfusion defects during pharmacologically induced coronary vasodilatation. Am J Physiol. 2001; 280; H1896H1904.
12. Pries AR, Secomb TW, Gessner T, et al. Resistance to blood flow in microvessels in vivo. Circ Res. 1994; 75: 904915.
13. Lowe GDO, McArdle BM, Stromberg P, et al. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet. 1982; 1: 472475.[CrossRef][Medline] [Order article via Infotrieve]
14. Seplowitz AH, Chien S, Smith FR. Effects of lipoproteins on plasma viscosity. Atherosclerosis. 1981; 38: 8995.[CrossRef][Medline] [Order article via Infotrieve]
15. Rim S-J, Leong-Poi H, Lindner JR, et al. The decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity. Circulation. 2001; 104: 27042709.
16. Yarnell JWG, Baker IA, Sweetman PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation. 1991; 83: 836844.
17. Rosenson RS, Lowe GDO. Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis. 1998; 140; 271280.[Medline] [Order article via Infotrieve]
18. Kohno M, Murakawa K, Yasunari K, et al. Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients. Metabolism. 1997; 46: 287291.[CrossRef][Medline] [Order article via Infotrieve]
19. Theilmeier G, Verhamme P, Dymarkowski M, et al. Hypercholesterolemia in minipigs impairs left ventricular response to stress: association with decreased coronary flow reserve and reduced capillary density. Circulation. 2002; 106: 11401146.
20. Bin JP, Le DE, Jayaweera AR, et al. Direct effects of dobutamine on the coronary microcirculation: comparison with adenosine using myocardial contrast echocardiography. J Am Soc Echocardiogr. 2003; 16: 871879.[CrossRef][Medline] [Order article via Infotrieve]
21. Linka AZ, Sklenar J, Wei K, et al. Spatial distribution of microbubble velocity and concentration within the myocardium: insight into transmural distribution of myocardial blood flow and volume. Circulation. 1998; 98; 19121920.[Medline] [Order article via Infotrieve]
22. Senior R, Lepper W, Pasquet A, et al. Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc-SPECT. Am Heart J. In press.
This article has been cited by other articles:
![]() |
V. Vaccarino, J. Votaw, T. Faber, E. Veledar, N. V. Murrah, L. R. Jones, J. Zhao, S. Su, J. Goldberg, J. P. Raggi, et al. Major Depression and Coronary Flow Reserve Detected by Positron Emission Tomography Arch Intern Med, October 12, 2009; 169(18): 1668 - 1676. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Maron, I. Olivotto, B. J. Maron, S. K. Prasad, F. Cecchi, J. E. Udelson, and P. G. Camici The case for myocardial ischemia in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 866 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Safar and P. Lacolley Disturbance of macro- and microcirculation: relations with pulse pressure and cardiac organ damage Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H1 - H7. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Gurfinkel, V. S. Lernoud, R. P. Laguens, and R. R. Favaloro Advances in Coronary Heart Disease Surgery in Latin America Circulation, March 6, 2007; 115(9): 1147 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Centurion The Open Artery Hypothesis: Beneficial Effects and Long-term Prognostic Importance of Patency of the Infarct-Related Coronary Artery Angiology, February 1, 2007; 58(1): 34 - 44. [Abstract] [PDF] |
||||
![]() |
T. Y. Wong, A. Kamineni, R. Klein, A. R. Sharrett, B. E. Klein, D. S. Siscovick, M. Cushman, and B. B. Duncan Quantitative Retinal Venular Caliber and Risk of Cardiovascular Disease in Older Persons: The Cardiovascular Health Study Arch Intern Med, November 27, 2006; 166(21): 2388 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Armstrong and W. A. Zoghbi Stress Echocardiography: Current Methodology and Clinical Applications J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1739 - 1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bodi, J. Sanchis, A. Losada, M. P. Lopez-Lereu, D. Garcia, M. Pellicer, F. J. Chorro, and A. Llacer Usefulness of quantitative intravenous myocardial contrast echocardiography to analyze microvasculature perfusion in patients with a recent myocardial infarction and an open infarct-related artery: comparison with intracoronary myocardial contrast echocardiography Eur J Echocardiogr, June 1, 2005; 6(3): 164 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsumoto, T. Asano, K. Mano, H. Tachibana, M. Todoh, M. Tanaka, and F. Kajiya Regional myocardial perfusion under exchange transfusion with liposomal hemoglobin: in vivo and in vitro studies using rat hearts Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1909 - H1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kaufmann and P. G. Camici Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications J. Nucl. Med., January 1, 2005; 46(1): 75 - 88. [Full Text] [PDF] |
||||
![]() |
J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics, December 1, 2004; 114(6): 1708 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Skalidis, F. I. Parthenakis, A. P. Patrianakos, M. I. Hamilos, and P. E. Vardas Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2027 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation, October 26, 2004; 110(17): 2747 - 2771. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Fearon, W. Aarnoudse, N. H.J. Pijls, B. De Bruyne, L. B. Balsam, D. T. Cooke, R. C. Robbins, P. J. Fitzgerald, A. C. Yeung, and P. G. Yock Microvascular Resistance Is Not Influenced by Epicardial Coronary Artery Stenosis Severity: Experimental Validation Circulation, May 18, 2004; 109(19): 2269 - 2272. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |